BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  North Carolina’s Hatteras Venture Scores $90 Million Life Sciences, Health IT Fund

  August 24, 2015

   · 

  4 min read
• RedHill Biopharma Ltd. Receives Notice Of Allowance For New Israeli Patent Covering RHB-104 For The Treatment Of Crohn’s Disease

  August 24, 2015

   · 

  7 min read
• Drug Development

  Regen BioPharma BORIS Gene Silencing Technology Successfully Utilized By Independent Researchers To Kill Breast Cancer And Colon Cancer Stem Cells

  August 24, 2015

   · 

  3 min read
• Biotech Bay

  Bio-Rad Launches Droplet Digital PCR Supermix For Direct Quantification Of Residual Host Cell DNA

  August 24, 2015

   · 

  2 min read
• Drug Development

  Revitalized Exelixis Grabs Breakthrough Tag for Cabozantinib

  August 24, 2015

   · 

  9 min read
• Drug Development

  Eisai Company Release: FYCOMPA (perampanel) CIII Demonstrates A Significant Reduction In Primary Generalized Tonic-Clonic (PGTC) Seizure Frequency In Phase 3 Trial Of Patients With Epilepsy Age 12 And Older

  August 24, 2015

   · 

  11 min read
• Business

  Bioquiddity And Lee’s Pharmaceutical Enter Agreement To Jointly Commercialize Two Infusion Pharmaceuticals In China, Taiwan, Hong Kong, And Macau

  August 24, 2015

   · 

  5 min read
• Drug Development

  Five Prime Announces Oral Presentation Of Initial Data From Ongoing Phase Ib Trial Of FP-1039/GSK3052230 In Squamous Non Small Cell Lung Cancer And Mesothelioma At World Conference On Lung Cancer

  August 24, 2015

   · 

  4 min read
• Drug Development

  Portage Biotech’s Biohaven’s Lead Drug Candidate Clears FDA Investigational New Drug Application (IND) Review And Clinical Studies To Begin

  August 24, 2015

   · 

  6 min read
• Drug Development

  Collegium Publishes Data From Xtampza ER Phase III Clinical Trial In The Journal PAIN

  August 24, 2015

   · 

  5 min read